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Abstract
IL-2 treatments have recently been identified to significantly reduce metastatic
melanoma tumors and in some cases eliminate them. The problem with these
treatments is that a set plan of administration varies from patient to patient and
methods for determining treatment steps are still in the process of being
developed. Previous research by Asad Usman and colleagues has used a numerical
technique using MATLAB to decide treatment protocols. This research used the
MATLAB’€
s built in ode15s function to addresses treatment procedures including
™
the starting and stopping of each treatment and the period in between each
treatment. Building on this data and existing model, my project will explore several
other numerical techniques such as other stiff solvers and a stepwise solution using
ode15s to study IL-2 tumors in metastatic melanoma patients. A stability analysis
will be made using Maple. The fixed points will be found and a Jacobian matrix will
be used to determine the eigenvalues and create a stability plot for the system.

Constants and other parameters
c= 0.00005
s1= 0
s2= 96000000

Stability Analysis

Antigenicity of tumor
Adoptive immunotherapy term, a constant influx
IL-2 therapy term, a constant influx

For small values of s2 we see no change in the tumor; however for large values of s2 we
see a clearing of the tumor. All constants and parameters were taken from actual
medical research. If values could not be found they were chosen to fit the patient data
that could be found.
Fixed Constants:
u2=.03
g1=20000000
a=1
p1=.1245

u3=10
g2=100000
b=0.000000001
p2=5

r2=.18
g3=1000

Background

Numerical Methods Used for Simulation
After trying to model the system using the built in MATLAB ode solvers, we
discovered this system of equations is a stiff system. These stiff systems arise
from large changes in variables in a short amount of time, and they create a
stability issue which caused the ode solvers to fail due to the divergence of the
system. In order to solve this system we added a relative tolerance function to
the solver, and also used a stepwise solution. A stability analysis was preformed
to demonstrate the challenges of the system. The six fixed points were
determined using Maple and a Jacobian matrix was used to find the eigenvalues
for each point. The eigenvalues help determine the stability of the system. A
phase portrait was also created using Maple in order to visual the stability
between each set of two variables.
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Conclusions
1. The Kirschner Model system is a stiff system, therefore the instability
causes regular built in Matlab solvers to fail.
2. The ode15s built in Matlab solver along with a relative tolerance function
can be used to solve the system.
3. A stepwise solution can also be used along with the ode15s solver to solve
the system.
4. The fixed points can be found using Maple. These values can be used to
calculate a Jacobian matrix to determine the eigenvalues of the system.
5. The calculated eigenvalues and a phase portrait plot give us information
about the stability of the system. Further study is needed to understand the
complete qualitative behavior of the model and the growth of cancer cells.

il2 Built in Solver
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il2 Simulations Looped Solver
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Effecto Cells, Tumor Cells, Cytokines
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Results

Tumor Model
The Kirschner model was used to simulate the interactions between three
parameters, effector cells, x, tumor cells, y, and interleukin IL-2, z. The
model predicts real situations in cancer patients. With no treatment 3 cases
can be observed. Low antigenicity, the ability of the cancer cells to bind to
the T-Lymphocytes, there is a stable state with large tumors. For moderate
antigenicities there is a large amplitude followed by a stable limit. For high
antigenicity there is a short amplitude followed by the destruction of the
tumor.

[

Jacobian matrix:

Effecto Cells, Tumor Cells, Cytokines

Cancer is a common disease caused by the unregulated growth and proliferation of
cells. This project focuses on metastatic melanoma which is a skin cancer caused
by a malignant tumor of melanocytes. Melanocytes are the body cells that
produce the dark pigment melanin and are responsible for skin color. Once these
cells become malignant they will experience metastasis which is when the tumor
cells bursts and the malignant cells travel to other parts of the body causing the
infection to spread. Although the mechanisms of cancer are not yet understood,
several hypotheses have given rise to effective treatments of this unregulated
growth. One treatment is chemotherapy. Although this method does kill cancer
cells there are many side effects because it also targets healthy cells causing
mutations or killing those cells too. Another treatment used is surgery for the
physical removal of mutant cells; however, these surgeries are very invasive and
complications can make the disease worse. A new treatment called adoptive
immunotherapy has been developed and has promising results because it uses the
body’s own immune system to fight the disease. Our bodies can respond to low
levels of precancerous or cancerous cells by recognizing the antigens and marking
these cells as “invader” cells. Our immune system is then programmed to destroy
this marked invader substance that is dangerous to the body. When tumors occur,
our body’s natural response is to activate T-Lymphocytes to destroy them. They
are activated by the interleukin IL-2. An interleukin is a protein mediator that
describes molecular messages between white blood cells and is very important in
adoptive immunotherapy. IL-2 has been artificially produced to stimulate the
immune systems of cancer patients specifically those with metastatic melanoma.
IL-2 treats tumors by stimulating the growth of tumor regression cells. Although IL2 has been successful in treating metastatic melanoma it also produces toxicity to
the patient. Because of this treatments need to be highly regulated and often
involve several doses. Mathematical modeling is currently being used to try to
create procedures specific to individual patient’s needs in order to help regulate IL2 treatments in order to make them more effective.
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